Hydroxychloroquine screening in the UK-closing the gaps.
作者信息
Gobbett Anne
机构信息
Sunderland Eye Infirmary, Sunderland, UK.
出版信息
Eye (Lond). 2021 Jun;35(6):1538-1540. doi: 10.1038/s41433-021-01411-6. Epub 2021 Jan 29.
Abstract
摘要
相似文献
1
Hydroxychloroquine screening in the UK-closing the gaps.英国的羟氯喹筛查——填补差距
Eye (Lond). 2021 Jun;35(6):1538-1540. doi: 10.1038/s41433-021-01411-6. Epub 2021 Jan 29.
2
The gathering storm: hydroxychloroquine retinopathy screening in the U.K.即将到来的风暴：英国的羟氯喹视网膜病变筛查
Br J Dermatol. 2017 Jun;176(6):1420-1421. doi: 10.1111/bjd.15567.
3
Screening for hydroxychloroquine toxicity.羟氯喹毒性筛查。
Ophthalmology. 2012 Jan;119(1):207; author reply 207-8. doi: 10.1016/j.ophtha.2011.09.041.
4
Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
Am J Ophthalmol. 2021 Feb;222:400-401. doi: 10.1016/j.ajo.2020.09.015. Epub 2020 Nov 20.
5
Hydroxychloroquine screening.羟氯喹筛查
Br J Ophthalmol. 2005 May;89(5):521-2. doi: 10.1136/bjo.2004.061473.
6
Screening for hydroxychloroquine toxicity in children.
Cutan Ocul Toxicol. 2013 Oct;32(4):344. doi: 10.3109/15569527.2013.781619. Epub 2013 Apr 22.
7
Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data.羟氯喹毒性的眼科监测：现有数据的科学综述
Br J Rheumatol. 1997 May;36(5):599-601. doi: 10.1093/rheumatology/36.5.599.
8
Hydroxychloroquine retinopathy: screening needed to prevent blindness.
Med J Aust. 2011 Jan 3;194(1):55. doi: 10.5694/j.1326-5377.2011.tb04161.x.
9
Hydroxychloroquine retinopathy: screening needed to prevent blindness.
Med J Aust. 2010 Jun 7;192(11):668-9. doi: 10.5694/j.1326-5377.2010.tb03676.x.
10
The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary.英国皇家眼科医学院关于对羟氯喹和氯喹使用者进行筛查的建议：执行摘要
Eye (Lond). 2018 Jul;32(7):1168-1173. doi: 10.1038/s41433-018-0136-x. Epub 2018 Jun 11.
引用本文的文献
1
Compliance With Hydroxychloroquine Screening Guidelines at a Large Academic Medical Center.大型学术医疗中心对羟氯喹筛查指南的遵循情况。
J Vitreoretin Dis. 2022 Jul 21;6(4):271-277. doi: 10.1177/24741264221097806. eCollection 2022 Jul-Aug.
本文引用的文献
1
SEQUENTIAL RETINAL THICKNESS ANALYSIS SHOWS HYDROXYCHLOROQUINE DAMAGE BEFORE OTHER SCREENING TECHNIQUES.序列视网膜厚度分析显示羟氯喹损害早于其他筛查技术。
Retin Cases Brief Rep. 2021 May 1;15(3):185-196. doi: 10.1097/ICB.0000000000001108.
2
Rheumatologists' perspective on hydroxychloroquine guidelines.风湿病学家对羟氯喹指南的看法。
Lupus Sci Med. 2020 Nov;7(1). doi: 10.1136/lupus-2020-000427.
3
Two years' experience of screening for hydroxychloroquine retinopathy.羟氯喹视网膜病变筛查两年经验
Eye (Lond). 2021 Apr;35(4):1171-1177. doi: 10.1038/s41433-020-1028-4. Epub 2020 Jul 7.
4
Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria.使用 2018 年皇家眼科医师学院诊断标准评估羟氯喹视网膜病变的患病率。
Eye (Lond). 2021 Jan;35(1):343-348. doi: 10.1038/s41433-020-1038-2. Epub 2020 Jun 25.
5
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).关于氯喹和羟氯喹视网膜病变筛查的建议（2016 年修订版）。
Ophthalmology. 2016 Jun;123(6):1386-94. doi: 10.1016/j.ophtha.2016.01.058. Epub 2016 Mar 16.
6
The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.长期羟氯喹治疗患者中毒性视网膜病变的风险。
JAMA Ophthalmol. 2014 Dec;132(12):1453-60. doi: 10.1001/jamaophthalmol.2014.3459.
7
Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.类风湿关节炎和系统性红斑狼疮患者羟氯喹视网膜毒性的发生率及预测因素。
Arthritis Care Res (Hoboken). 2010 Jun;62(6):775-84. doi: 10.1002/acr.20133.
8
Ocular toxicity of hydroxychloroquine.羟氯喹的眼部毒性。
Hong Kong Med J. 2006 Aug;12(4):294-304.
9
Retinopathy following chloroquine therapy.氯喹治疗后的视网膜病变。
Lancet. 1959 Oct 3;2(7101):478-80. doi: 10.1016/s0140-6736(59)90604-x.
10
Lupus erythematosus treated with chloroquine.用氯喹治疗的红斑狼疮。
Lancet. 1953 Jul 25;265(6778):201-2. doi: 10.1016/s0140-6736(53)90138-x.
Zotero 插件